DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Ignatiadis M, Litière S, Rothe F. et al.
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
Ann Oncol 2018;
29: 1777-1783
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.